Tata Institute introduces Rs 100 drug to prevent cancer recurrence; Doctors will soon begin human trials. | Top Vip News
[ad_1] Researchers at the Tata Institute in Mumbai announced the development of a new drug aimed at preventing cancer recurrence, according to a report in Hindustan Times. Researchers and doctors at the institute worked for 10 years and have now created a tablet that they claim would stop cancer from appearing in patients for the … Read more